Research has always been a priority of the PronoKal Group® as a committed company.
We therefore engage in extensive R&D in methods, products and services, from the research and development of new treatment methods and a more extensive line of products, to the development of new services in order to address the needs, demands and concerns of our patients.
This important R&D activity shows our commitment to excellence and ongoing improvement:
In addition to R&D, significant investment is made in our own research through scientific studies which prove the safety and effectiveness of our methods.
Abac backs PronoKal MBO [04/06/2017 • realdeals.eu.com]
Abac Solutions acquires PronoKal Group [04/05/2017 • Private Equity Wire]
Contact with your country
Suscribirse a las noticias de PronoKal Group® - RSS
2013 © PronoKal Group®